MINK THERAPEUTICS INC
0.6780
08-October-24 15:59:58
15 minutes delayed
Stocks
-0.0321
-4.52%
Today's range
0.5700 - 0.7200
ISIN
N/A
Source
NASDAQ
-
MiNK Therapeutics to Report Third Quarter 2022 Financial Results and Business Update
20 Oct 2022 09:00:01 By Nasdaq GlobeNewswire
-
MiNK Therapeutics to Host R&D Event November 10, 2022
05 Oct 2022 09:16:53 By Nasdaq GlobeNewswire
-
05 Oct 2022 08:30:00 By Nasdaq GlobeNewswire
-
MiNK Therapeutics to Participate at Upcoming Investor Conferences
31 Aug 2022 09:00:00 By Nasdaq GlobeNewswire
-
MiNK Therapeutics Reports Corporate Update and Second Quarter 2022 Financial Results
09 Aug 2022 08:00:02 By Nasdaq GlobeNewswire
-
MiNK Therapeutics to Participate at BTIG Biotechnology Conference
02 Aug 2022 08:30:00 By Nasdaq GlobeNewswire
-
MiNK Therapeutics to Report Second Quarter 2022 Financial Results and Business Update
27 Jul 2022 08:30:00 By Nasdaq GlobeNewswire
-
MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
25 May 2022 08:30:00 By Nasdaq GlobeNewswire
-
MiNK Therapeutics Corporate Update and First Quarter 2022 Financial Report
10 May 2022 08:00:03 By Nasdaq GlobeNewswire
-
MiNK Therapeutics to Report First Quarter 2022 Financial Results and Business Update
27 Apr 2022 17:19:52 By Nasdaq GlobeNewswire
-
18 Mar 2022 08:30:00 By Nasdaq GlobeNewswire
-
MiNK Therapeutics to Report Fourth Quarter & Full Year 2021 Financial Results and Business Update
03 Mar 2022 16:35:18 By Nasdaq GlobeNewswire
-
MiNK Therapeutics Announces Patients Dosed with AgenT-797 iNKT Cell Therapy in Solid Tumor Cancers
03 Mar 2022 09:28:47 By Nasdaq GlobeNewswire
-
MiNK Therapeutics to Participate at Upcoming B. Riley Securities Virtual Oncology Conference
12 Jan 2022 09:41:30 By Nasdaq GlobeNewswire
-
MiNK Therapeutics to Participate in 4th Annual Evercore ISI HealthCONx Conference
17 Nov 2021 16:15:00 By Nasdaq GlobeNewswire
-
12 Nov 2021 07:00:01 By Nasdaq GlobeNewswire